Health · 3 views
Rare eye condition prompts new FDA warning on popular GLP-1 drugs
The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss.
Summary
The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss. The condition is called non-arteritic anterior ischemic optic neuropathy (NAION). It happens when blood flow drops to part of the optic nerve, which carries signals from the eye to the brain.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Bioengineered Liver System Passes Safety Test in Phase I TrialContinue reading
- More Women on Testosterone; Hormone Patch Updates; Drug-Induced Bone LossContinue reading
- Experimental cell therapy improves skin resilience, advancing treatments for skin injuriesContinue reading
- How babies are born knowing the difference between day and nightContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow